These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
97 related articles for article (PubMed ID: 8838038)
1. Course of severe ulcerative colitis in northern India. Gulati R; Rawal KK; Kumar N; Jain M; Puri AS; Govil A; Sachdeva AK; Chaudhary A Trop Gastroenterol; 1995; 16(3):19-23. PubMed ID: 8838038 [TBL] [Abstract][Full Text] [Related]
2. Short-term efficacy and long-term outcome of cyclosporine treatment in patients with severe ulcerative colitis. Wenzl HH; Petritsch W; Aichbichler BW; Hinterleitner TA; Fleischmann G; Krejs GJ Z Gastroenterol; 1998 Apr; 36(4):287-93. PubMed ID: 9612926 [TBL] [Abstract][Full Text] [Related]
3. Intravenous tobramycin and metronidazole as an adjunct to corticosteroids in acute, severe ulcerative colitis. Mantzaris GJ; Hatzis A; Kontogiannis P; Triadaphyllou G Am J Gastroenterol; 1994 Jan; 89(1):43-6. PubMed ID: 8273796 [TBL] [Abstract][Full Text] [Related]
4. Outcome of a conservative approach in severe ulcerative colitis. Daperno M; Sostegni R; Scaglione N; Ercole E; Rigazio C; Rocca R; Pera A Dig Liver Dis; 2004 Jan; 36(1):21-8. PubMed ID: 14971812 [TBL] [Abstract][Full Text] [Related]
5. Prognosis of severe attacks in ulcerative colitis: effect of intensive medical treatment. Benazzato L; D'Incà R; Grigoletto F; Perissinotto E; Medici V; Angriman I; Sturniolo GC Dig Liver Dis; 2004 Jul; 36(7):461-6. PubMed ID: 15285525 [TBL] [Abstract][Full Text] [Related]
6. Colectomy rate in acute severe ulcerative colitis in the infliximab era. Aratari A; Papi C; Clemente V; Moretti A; Luchetti R; Koch M; Capurso L; Caprilli R Dig Liver Dis; 2008 Oct; 40(10):821-6. PubMed ID: 18472316 [TBL] [Abstract][Full Text] [Related]
7. Infliximab as a rescue therapy for hospitalized patients with severe ulcerative colitis refractory to systemic corticosteroids. Yamamoto-Furusho JK; Uzcanga LF Dig Surg; 2008; 25(5):383-6. PubMed ID: 19005257 [TBL] [Abstract][Full Text] [Related]
8. Continuous infusion versus bolus administration of steroids in severe attacks of ulcerative colitis: a randomized, double-blind trial. Bossa F; Fiorella S; Caruso N; Accadia L; Napolitano G; Valvano MR; Andriulli A; Annese V Am J Gastroenterol; 2007 Mar; 102(3):601-8. PubMed ID: 17156148 [TBL] [Abstract][Full Text] [Related]
9. Review article: the management of mild to severe acute ulcerative colitis. Travis SP Aliment Pharmacol Ther; 2004 Oct; 20 Suppl 4():88-92. PubMed ID: 15352901 [TBL] [Abstract][Full Text] [Related]
10. Long-term colectomy rate after intensive intravenous corticosteroid therapy for ulcerative colitis prior to the immunosuppressive treatment era. Gustavsson A; Halfvarson J; Magnuson A; Sandberg-Gertzén H; Tysk C; Järnerot G Am J Gastroenterol; 2007 Nov; 102(11):2513-9. PubMed ID: 17680849 [TBL] [Abstract][Full Text] [Related]
11. A retrospective analysis of the efficacy and safety of infliximab as rescue therapy in acute severe ulcerative colitis. Lees CW; Heys D; Ho GT; Noble CL; Shand AG; Mowat C; Boulton-Jones R; Williams A; Church N; Satsangi J; Arnott ID; Aliment Pharmacol Ther; 2007 Aug; 26(3):411-9. PubMed ID: 17635376 [TBL] [Abstract][Full Text] [Related]
12. Infliximab for the treatment of ulcerative colitis: outcomes in Oxford from 2000 to 2006. Jakobovits SL; Jewell DP; Travis SP Aliment Pharmacol Ther; 2007 May; 25(9):1055-60. PubMed ID: 17439506 [TBL] [Abstract][Full Text] [Related]
13. Relapses of inflammatory bowel disease during pregnancy: in-hospital management and birth outcomes. Reddy D; Murphy SJ; Kane SV; Present DH; Kornbluth AA Am J Gastroenterol; 2008 May; 103(5):1203-9. PubMed ID: 18422816 [TBL] [Abstract][Full Text] [Related]
14. [Frequency and predictive factors of colectomy and restorative colo-proctectomy in ulcerative colitis]. Karoui S; Serghini M; Chaieb M; Jomni T; Kallel L; Fekih M; Matri S; Boubaker J; Filali A Tunis Med; 2009 Feb; 87(2):115-9. PubMed ID: 19522443 [TBL] [Abstract][Full Text] [Related]
15. Cyclosporin for severe ulcerative colitis. Naftali T; Novis B; Pomeranz I; Leichtman G; Maor Y; Shapiro R; Moskowitz M; Avidan B; Avni Y; Bujanover Y; Fireman Z Isr Med Assoc J; 2000 Aug; 2(8):588-91. PubMed ID: 10979350 [TBL] [Abstract][Full Text] [Related]
16. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Ho GT; Mowat C; Goddard CJ; Fennell JM; Shah NB; Prescott RJ; Satsangi J Aliment Pharmacol Ther; 2004 May; 19(10):1079-87. PubMed ID: 15142197 [TBL] [Abstract][Full Text] [Related]
17. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal. Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172 [TBL] [Abstract][Full Text] [Related]
18. Current management of severe ulcerative colitis. Caprilli R; Viscido A; Latella G Nat Clin Pract Gastroenterol Hepatol; 2007 Feb; 4(2):92-101. PubMed ID: 17268544 [TBL] [Abstract][Full Text] [Related]
19. Intravenous cyclosporin in ulcerative colitis: a five-year experience. Cohen RD; Stein R; Hanauer SB Am J Gastroenterol; 1999 Jun; 94(6):1587-92. PubMed ID: 10364029 [TBL] [Abstract][Full Text] [Related]
20. Intravenous cyclosporine for the treatment of severe steroid refractory ulcerative colitis: what is the cost? Poritz LS; Rowe WA; Swenson BR; Hollenbeak CS; Koltun WA Dis Colon Rectum; 2005 Sep; 48(9):1685-90. PubMed ID: 16007496 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]